Rising prescription drug sales and continued recovery of Johnson & Johnson's beleaguered consumer health business in the third quarter helped the health care giant overcome slumping medical device sales. For the second straight quarter, the maker of baby shampoo and immune disorder drugs nudged up its 2013 earnings forecast by a few cents, to $5.44 to $5.49 per share. Pain relievers Tylenol and ...
Business For Sale in Miami News Snippet brought to you by: BizLocal.com
BizLocal provides a Business For Sale Market Place and more.
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.
Call 800-785-2925 for more information.